Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis

P Gisondi, G Altomare, F Ayala, F Bardazzi, L Bianchi, A Chiricozzi, A Costanzo, A Conti, P Dapavo, C De Simone, C Foti, L Naldi, A Offidani, A Parodi, S Piaserico, F Prignano, F Rongioletti, L Stingeni, M Talamonti, G Girolomoni

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence-based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75% of the voting experts according to the Delphi procedure.

Original languageEnglish
Pages (from-to)774-790
Number of pages17
JournalJournal of the European Academy of Dermatology and Venereology
Volume31
Issue number5
DOIs
Publication statusPublished - May 2017

Fingerprint

Psoriasis
Guidelines
Dermatology
Therapeutics
Venereology
Evidence-Based Medicine
Therapeutic Uses
Politics
Italy
Patient Care
Delivery of Health Care
Pharmaceutical Preparations
Population

Keywords

  • Letter

Cite this

Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. / Gisondi, P; Altomare, G; Ayala, F; Bardazzi, F; Bianchi, L; Chiricozzi, A; Costanzo, A; Conti, A; Dapavo, P; De Simone, C; Foti, C; Naldi, L; Offidani, A; Parodi, A; Piaserico, S; Prignano, F; Rongioletti, F; Stingeni, L; Talamonti, M; Girolomoni, G.

In: Journal of the European Academy of Dermatology and Venereology, Vol. 31, No. 5, 05.2017, p. 774-790.

Research output: Contribution to journalArticle

Gisondi, P, Altomare, G, Ayala, F, Bardazzi, F, Bianchi, L, Chiricozzi, A, Costanzo, A, Conti, A, Dapavo, P, De Simone, C, Foti, C, Naldi, L, Offidani, A, Parodi, A, Piaserico, S, Prignano, F, Rongioletti, F, Stingeni, L, Talamonti, M & Girolomoni, G 2017, 'Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis', Journal of the European Academy of Dermatology and Venereology, vol. 31, no. 5, pp. 774-790. https://doi.org/10.1111/jdv.14114
Gisondi, P ; Altomare, G ; Ayala, F ; Bardazzi, F ; Bianchi, L ; Chiricozzi, A ; Costanzo, A ; Conti, A ; Dapavo, P ; De Simone, C ; Foti, C ; Naldi, L ; Offidani, A ; Parodi, A ; Piaserico, S ; Prignano, F ; Rongioletti, F ; Stingeni, L ; Talamonti, M ; Girolomoni, G. / Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. In: Journal of the European Academy of Dermatology and Venereology. 2017 ; Vol. 31, No. 5. pp. 774-790.
@article{bc6e8215a98946d197b2fc67b361c5de,
title = "Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis",
abstract = "Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence-based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75{\%} of the voting experts according to the Delphi procedure.",
keywords = "Letter",
author = "P Gisondi and G Altomare and F Ayala and F Bardazzi and L Bianchi and A Chiricozzi and A Costanzo and A Conti and P Dapavo and {De Simone}, C and C Foti and L Naldi and A Offidani and A Parodi and S Piaserico and F Prignano and F Rongioletti and L Stingeni and M Talamonti and G Girolomoni",
note = "{\circledC} 2017 European Academy of Dermatology and Venereology.",
year = "2017",
month = "5",
doi = "10.1111/jdv.14114",
language = "English",
volume = "31",
pages = "774--790",
journal = "Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "wiley",
number = "5",

}

TY - JOUR

T1 - Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis

AU - Gisondi, P

AU - Altomare, G

AU - Ayala, F

AU - Bardazzi, F

AU - Bianchi, L

AU - Chiricozzi, A

AU - Costanzo, A

AU - Conti, A

AU - Dapavo, P

AU - De Simone, C

AU - Foti, C

AU - Naldi, L

AU - Offidani, A

AU - Parodi, A

AU - Piaserico, S

AU - Prignano, F

AU - Rongioletti, F

AU - Stingeni, L

AU - Talamonti, M

AU - Girolomoni, G

N1 - © 2017 European Academy of Dermatology and Venereology.

PY - 2017/5

Y1 - 2017/5

N2 - Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence-based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75% of the voting experts according to the Delphi procedure.

AB - Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, appropriate use of therapeutic resources is very important. Management of psoriasis in daily clinical practice is highly variable because many issues are still debated and not definitely addressed by the evidence-based medicine. Moreover, the different availability and reimbursability of drugs in each country justifies national guidelines. Expert consensus can provide helpful guidelines for optimizing patient care. A total of 20 dermatologists from different areas of Italy and with large experience in the treatment of psoriasis agreed to participate in the guidelines expert panel who aimed to reach consensus on the factors influencing psoriasis severity, the indications for systemic treatments, the parameters to be considered in the choice of treatment, and the factors to be considered in the choice of biological treatment. The recommendations for the use, screening and monitoring of systemic therapies were based on the 2015 S3 European Dermatology Forum/European Academy of Dermatology and Venereology psoriasis guidelines. Recommendations on the treatment of psoriasis in special patient populations were also agreed. The final document was discussed in a meeting moderated by a facilitator with participation of the entire group and adopting a nominal group technique to reach consensus. A statement was regarded as consented when agreement was achieved by at least 75% of the voting experts according to the Delphi procedure.

KW - Letter

U2 - 10.1111/jdv.14114

DO - 10.1111/jdv.14114

M3 - Article

VL - 31

SP - 774

EP - 790

JO - Journal of the European Academy of Dermatology and Venereology

JF - Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 5

ER -